<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01113229</url>
  </required_header>
  <id_info>
    <org_study_id>P 081104</org_study_id>
    <secondary_id>2009-013177-18</secondary_id>
    <nct_id>NCT01113229</nct_id>
  </id_info>
  <brief_title>Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage</brief_title>
  <acronym>CYTOCINON</acronym>
  <official_title>Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum
      haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective :

      To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum
      haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks'.

      Method :

      Double blinded Randomized controlled trial in two centers over 30 months.

      Treatment :

      Patients will be randomly allocated into one of the two following group :

      Group A : 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and
      two misoprostol tablets taken orally (400µg) following cord clamp.

      Group B: 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two
      placebo tablets taken orally following cord clamp.

      Number of patients:

      1550 patients per group (one third reduction of occurrence with alpha and beta set at 0.05
      and 0.20 respectively). Patients were included in the study during 48 hours.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    reason of halt prematurely: futility of the trial
  </why_stopped>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of post partum hemorrhage &gt; 500mL in 1 hour</measure>
    <time_frame>1 HOUR</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of post partum hemorrhage &gt; 1000mL in 1 hour</measure>
    <time_frame>1 HOUR</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1721</enrollment>
  <condition>Hemorrhage; Complicating Delivery</condition>
  <arm_group>
    <arm_group_label>Misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400µg) following cord clamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>two misoprostol tablets taken orally (400µg)</description>
    <arm_group_label>Misoprostol</arm_group_label>
    <arm_group_label>PLACEBO</arm_group_label>
    <other_name>two misoprostol tablets taken orally (400µg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women&gt;18 years,

          -  during first stage of normal labor,

          -  at 36 to 42 weeks,

          -  with epidural analgesia and informed signed consent

        Exclusion Criteria:

          -  Cesarean section delivery,

          -  clotting disorders,

          -  prostaglandin allergy,

          -  absent consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Rozenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI POISSY ST GERMAIN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chi Poissy St Germain</name>
      <address>
        <city>Poissy</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2010</study_first_submitted>
  <study_first_submitted_qc>April 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2010</study_first_posted>
  <last_update_submitted>April 7, 2015</last_update_submitted>
  <last_update_submitted_qc>April 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post Partum Haemorrhage,</keyword>
  <keyword>oxytocin,</keyword>
  <keyword>misoprostol,</keyword>
  <keyword>prevention,</keyword>
  <keyword>delivery.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

